which glp 1 is approved for weight loss GLP-1 Medications: Everything You Need to Know Comparing GLP‑1 Drugs With Other

Each of these companies has its own coverage options and policies, which are subject to change at any time

Starting July 2026, Wegovy is also one of the three drugs covered under the GLP-1 Bridge program for weight loss at a $50/month copay, manufactured by Novo Nordisk

The published case report describing severe psychiatric symptoms, including paranoia and hallucinations, involved compounded tirzepatide

ZKA, RV, and JS-L designed the study

obviously each of these has very different business models (for example, DRI and CMG are almost completely company owned, while WING is almost exclusively franchised) and are at different places in their growth life cycle, so each deserves slightly (or massively!) different multiples and valuations, but, across the board, these multiples seem pretty rich even in a vacuum